122
Views
3
CrossRef citations to date
0
Altmetric
Commentary on selected article in this issue

Splenectomy and second malignancies in patients with Hodgkin lymphoma

, , , , &
Pages 230-231 | Received 31 Jan 2014, Accepted 25 Mar 2014, Published online: 12 May 2014

References

  • Santos FP, Tam CS, Kantarjian H, et al. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leuk Lymphoma 2014;55:121–127.
  • Lenglet J, Traulle C, Mounier N, et al. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment. Leuk Lymphoma 2013 Nov 11. [Epub ahead of print]
  • van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994;12:312–325.
  • Dietrich PY, Henry-Amar M, Cosset JM, et al. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?Blood 1994;84:1209–1215.
  • Wahner-Roedler DL, Nelson DF, Croghan IT, et al. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 2003;78:708–715.
  • Abrahamsen JF, Andersen A, Hannisdal E, et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. J Clin Oncol 1993;11:255–261.
  • Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745–751.
  • Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks:new representations of old estimators. Stat Med 1999;18:695–706.
  • Hodgson DC. Late effects in the era of modern therapy for hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2011:323–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.